[Comment on Borrelia burgdorferi Group infections].
Bózsik
Béla Pál
BP
D000907:Antibodies, Bacterial / Q000302:isolation & purification; D015748:Borrelia burgdorferi Group / Q000187:drug effects* / Q000302:isolation & purification; D002443:Ceftriaxone / Q000494:pharmacology; D002939:Ciprofloxacin / Q000494:pharmacology; D017291:Clarithromycin / Q000494:pharmacology; D004318:Doxycycline / Q000494:pharmacology; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D015570:Josamycin / Q000494:pharmacology; D008193:Lyme Disease / Q000188:drug therapy*
D000907:Antibodies, Bacterial; D002939:Ciprofloxacin; D002443:Ceftriaxone; D017291:Clarithromycin; D015570:Josamycin; D004318:Doxycycline
Hozzászólás a Borrelia burgdorferi sensu lato kérdésköréhez.